Company Filing History:
Years Active: 2022-2025
Title: Innovations of Yangfeng Li
Introduction
Yangfeng Li is a prominent inventor based in Chicago, IL (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific biological pathways. With a total of 4 patents to his name, his work has the potential to impact various clinical conditions.
Latest Patents
One of Yangfeng Li's latest patents is titled "Substituted benzothiophene analogs as selective estrogen receptor degraders." This patent focuses on substituted benzothiophene analogs that serve as selective degraders of the estrogen receptor. The methods of making these compounds, along with pharmaceutical compositions that include them, are also discussed. This innovation aims to address clinical conditions associated with the estrogen receptor, such as breast cancer and osteoporosis.
Another notable patent is "Pyridinone-based epigenetic modifiers and uses thereof." This patent describes pyridinone-based compounds and their derivatives, along with pharmaceutical formulations. These compounds can be administered to subjects in need and have the potential to modulate the activity and function of BRD and BET proteins.
Career Highlights
Yangfeng Li is affiliated with the University of Illinois, where he conducts his research and development work. His academic background and ongoing research contribute to the advancement of pharmaceutical sciences.
Collaborations
Yangfeng Li has collaborated with notable colleagues, including Gregory R. Thatcher and Rui Xiong. These collaborations enhance the scope and impact of his research efforts.
Conclusion
Yangfeng Li's innovative work in pharmaceuticals, particularly through his recent patents, showcases his commitment to addressing critical health issues. His contributions are paving the way for new therapeutic options in the medical field.